Author

Yin Mo

Observed names: Dr. Yin Mo, M Yin, Mo Yin, Mo, Yin, Y Mo, Y. Mo, Yin, Mo

Institutions: National University of Singapore, Mahidol University, University of Oxford, Duke-NUS Medical School, Mahidol Oxford Tropical Medicine Research Unit, National University Hospital, National University Hospital, National University Health System

Observed institutions: Ministry of Health, National University of Singapore, Nanyang Technological University, Singapore General Hospital, Mahidol University, Angkor Hospital for Children, Tan Tock Seng Hospital, University of Oxford, World Health Organization, Duke-NUS Medical School, Mahidol Oxford Tropical Medicine Research Unit, National University Hospital, National University Hospital, National University Health System, National Centre for Infectious Diseases, University College London, Genome Institute of Singapore

ORCID: 0000-0002-0216-9550

Observed ORCID: 0000-0002-0216-9550

OpenAlex ID: A5019831713

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance

2018 · Patrick N. A. Harris, Paul A. Tambyah, et al. · JAMA · 776

PDF

Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study

2020 · A Henderson, D L Paterson, et al. · Clinical Infectious Diseases · 161

A review of treatment modalities for Middle East Respiratory Syndrome

2016 · Yin Mo, Dale Fisher · Journal of Antimicrobial Chemotherapy · 100

PDF

Using machine learning to guide targeted and locally-tailored empiric antibiotic prescribing in a children's hospital in Cambodia

2018 · Mathupanee Oonsivilai, Mo Yin, et al. · Wellcome Open Research · 95

PDF

Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27

2017 · Patrick N A Harris, Nouri L Ben Zakour, et al. · Journal of Antimicrobial Chemotherapy · 82

PDF

Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study

2021 · Yin Mo, David W. Eyre, et al. · PLoS Medicine · 73

Non-adherence in non-inferiority trials: pitfalls and recommendations

2020 · Yin Mo, Cherry Lim, et al. · BMJ · 68

PDF

Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial

2024 · Yin Mo, Suchart Booraphun, et al. · The Lancet Respiratory Medicine · 66

PDF

A meta‐analysis of the association between Helicobacter pylori ( H. pylori ) infection and hyperemesis gravidarum

2017 · Qin Xiang Ng, Nandini Venkatanarayanan, et al. · Helicobacter · 59

Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae

2015 · Patrick N A Harris, Mo Yin, et al. · Antimicrobial Resistance and Infection Control · 56

PDF

The burden and dynamics of hospital-acquired SARS-CoV-2 in England

2023 · Ben S. Cooper, Stephanie Evans, et al. · Nature · 53

PDF

Implications of reducing antibiotic treatment duration for antimicrobial resistance in hospital settings: A modelling study and meta-analysis

2023 · Yin Mo, Mathupanee Oonsivilai, et al. · PLoS Medicine · 52

The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020

2022 · Gwenan M. Knight, Thi Mui Pham, et al. · BMC Infectious Diseases · 49

PDF

Zika virus—a review for clinicians

2016 · Yin Mo, Brenda Mae Alferez Salada, et al. · British Medical Bulletin · 47

A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance

2023 · Sheila Rose Varadan, Clare Isobel Rosina Chandler, et al. · The Lancet · 45

A systematic review of the use of rifaximin for Clostridium difficile infections

2018 · Qin Xiang Ng, Wayren Loke, et al. · Anaerobe · 39

Quantifying antibiotic impact on within-patient dynamics of extended-spectrum beta-lactamase resistance

2020 · Rene Niehus, Esther van Kleef, et al. · eLife · 33

Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults

2014 · Patrick N A Harris, Alvin D Wang, et al. · The Lancet Infectious Diseases · 31

PDF

WHO revised bacterial priority pathogens list to encourage global actions to combat AMR

2024 · Yingying Ma, Pan Chen, et al. · hLife · 30

Duration of Carbapenemase-Producing Enterobacteriaceae Carriage in Hospital Patients

2020 · Yin Mo, Anastasia Hernandez-Koutoucheva, et al. · Emerging infectious diseases · 29

PDF

Antibiotic duration for common bacterial infections—a systematic review

2024 · Yin Mo, Wei Cong Tan, et al. · JAC-Antimicrobial Resistance · 27

Artificial intelligence and infectious diseases: tackling antimicrobial resistance, from personalised care to antibiotic discovery

2025 · Alex Howard, Nada Reza, et al. · The Lancet Infectious Diseases · 24

Rapid Diagnostics for Antibiotic Resistance: Urgent Need for Strong Clinical Evidence

2022 · Yin Mo · Clinical Infectious Diseases · 24

Relating knowledge, attitude and practice of antibiotic use to extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage: results of a cross-sectional community survey

2019 · Yin Mo, Ivan Seah, et al. · BMJ Open · 24

PDF

Effectiveness of infection prevention and control interventions, excluding personal protective equipment, to prevent nosocomial transmission of SARS-CoV-2: a systematic review and call for action

2021 · Yalda Jafari, Mo Yin, et al. · Infection Prevention in Practice · 21

PDF

Works count: 98

Citation count: 2,446

H-index: 24

I10-index: 40